Genentech (RHHBY) Receives FDA Priority Review for Lucentis as mCNV Treatment
Go back to Genentech (RHHBY) Receives FDA Priority Review for Lucentis as mCNV Treatment| Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) | Delayed: 30.98 +0.08 (0.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.90 | 52 Week High | $35.13 | |||
| Open | $30.95 | 52 Week Low | $28.10 | |||
| Day High | $31.11 | P/E | N/A | |||
| Day Low | $30.94 | EPS | $0.00 | |||
| Volume | 856,797 | |||||
| Brown & Brown, Inc. (NYSE: RO) | Delayed: 8.49 +0.55 (6.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.94 | 52 Week High | $8.59 | |||
| Open | $7.94 | 52 Week Low | $7.82 | |||
| Day High | $8.59 | P/E | 6.53 | |||
| Day Low | $7.82 | EPS | $1.30 | |||
| Volume | 42,732 | |||||
| ROGERS CORPORATION (NYSE: ROG) | Delayed: 119.70 -0.94 (0.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $120.64 | 52 Week High | $76.55 | |||
| Open | $120.79 | 52 Week Low | $41.92 | |||
| Day High | $121.82 | P/E | 67.63 | |||
| Day Low | $119.15 | EPS | $1.77 | |||
| Volume | 16,328 | |||||
